We are live on ! Find out more
ARIA

Ariad Pharmaceuticals Inc
ARIA

Delisted

ARIA was delisted on the 15th of February, 2017.

Back to rankings

198 hedge funds and large institutions have $2.69B invested in Ariad Pharmaceuticals Inc in 2013 Q2 according to their latest regulatory filings, with 198 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

1% more call options, than puts

Call options by funds: $16M | Put options by funds: $15.8M

Holders
198
Holders Change
+198
Holders Change %
–
% of All Funds
6.46%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
% of All Funds
0.16%
New
198
Increased
–
Reduced
–
Closed
–
Calls
$16M
Puts
$15.8M
Net Calls
+$187K
Net Calls Change
+$187K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
MLICM
151
Metropolitan Life Insurance Company (MetLife)
New York
$225K +$228K +12,875 New
AA
152
ALPS Advisors
Colorado
$223K +$226K +12,740 New
AWCI
153
Alpine Woods Capital Investors
New York
$219K +$222K +12,500 New
Teacher Retirement System of Texas
154
Teacher Retirement System of Texas
Texas
$219K +$222K +12,517 New
PA
155
Pinnacle Associates
New York
$214K +$217K +12,250 New
PAM
156
Paradigm Asset Management
New York
$209K +$212K +11,950 New
Natixis Advisors
157
Natixis Advisors
Massachusetts
$192K +$195K +11,004 New
HSBC Holdings
158
HSBC Holdings
United Kingdom
$191K +$193K +10,891 New
NI
159
Numeric Investors
Massachusetts
$190K +$192K +10,840 New
SCM
160
Stux Capital Management
New York
$187K +$190K +10,700 New
RCM
161
Reynolds Capital Management
Nevada
$181K +$183K +10,300 New
William Blair & Company
162
William Blair & Company
Illinois
$180K +$183K +10,330 New
PA
163
Profund Advisors
Maryland
$179K +$181K +10,236 New
FDCC
164
Foster Dykema Cabot & Co
Massachusetts
$178K +$181K +10,200 New
LTFS
165
Ladenburg Thalmann Financial Services
Florida
$171K +$173K +9,747 New
Royal Bank of Canada
166
Royal Bank of Canada
Ontario, Canada
$147K +$149K +8,419 New
DADC
167
D.A. Davidson & Co
Montana
$138K +$141K +7,932 New
ILIM
168
Irish Life Investment Managers
Ireland
$131K +$133K +7,504 New
US Bancorp
169
US Bancorp
Minnesota
$129K +$131K +7,376 New
MA
170
MUFG Americas
New York
$107K +$108K +6,100 New
ST
171
Spot Trading
Illinois
$98K +$99.2K +5,597 New
Baillie Gifford & Co
172
Baillie Gifford & Co
United Kingdom
$93K +$94.4K +5,327 New
Creative Planning
173
Creative Planning
Kansas
$87K +$88.6K +4,996 New
BRWA
174
B. Riley Wealth Advisors
Florida
$87K +$88.6K +5,000 New
ECAM
175
East Coast Asset Management
Massachusetts
$72K +$72.6K +4,095 New
4 5 6
7
8

ARIA Hedge Fund Activity: Q2 2013 in Review

198 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in Ariad Pharmaceuticals Inc (ARIA) for Q2 2013, worth a combined $2.69B.

Buyers outnumbered sellers: 198 funds opened new ARIA positions and 0 closed out — a net gain of 198 holders — while 0 added to existing stakes and 0 trimmed.

  • 198 institutional investors held Ariad Pharmaceuticals Inc (ARIA) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $2.69B of Ariad Pharmaceuticals Inc stock for Q2 2013.
  • 198 funds opened new Ariad Pharmaceuticals Inc positions in Q2 2013 and 0 closed out, a net change of +198 holders.

Based on aggregated 13F filings for Q2 2013.